ATM and non-small cell lung carcinoma: Further illustrating the late responses in patients with ATM LOF tumors, after the data cutoff, a patient with advanced non-small cell lung cancer (NSCLC) and a germline ATM LOF tumor had a RECIST 1.1 PR after 37 weeks of treatment (Table 3).